Medical Care

Global Fecal Transplant Treatment Market Research Report 2025

The global market for Fecal Transplant Treatment was valued at US$ 1032 million in the year 2024 and is projected to reach a revised size of US$ 1627 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Fecal transplant treatment is a therapy that transplants functional flora from the feces of healthy donors into the patient's intestines to rebuild the balance of intestinal microorganisms and treat intestinal and extraintestinal diseases. Its core principle is to use healthy flora to inhibit pathogenic microorganisms, repair intestinal barrier function and regulate the immune system, and improve the pathological state caused by flora imbalance through flora transplantation. Fecal transplant treatment is suitable for exploratory treatment of Clostridium difficile infection (CDI), inflammatory bowel disease (IBD) (ulcerative colitis, Crohn's disease), irritable bowel syndrome (IBS), metabolic syndrome (obesity, diabetes), neurological diseases (autism, Parkinson's disease), etc.
From the perspective of the global market, fecal transplant treatment continues to develop. North America dominates the market, and companies such as OpenBiome and Finch Therapeutics are promoting commercialization. The European Union classifies FMT as an "advanced therapeutic medicinal product (ATMP)" and requires standardized production. The United Kingdom and the Netherlands are leading in clinical trials and flora construction. In the Asia-Pacific region, the research progress in China and India is accelerating, but it will take a long time to achieve commercialization. The intensification of antibiotic resistance, breakthroughs in microbiome research, and the continuous improvement of regulatory policies are all driving the continuous development of fecal transplantation therapy. Manufacturers' competition focuses on standardized production and expanded indications. However, safety disputes, regulatory complexity, and patient acceptance all limit the rapid development of fecal transplantation therapy. In general, fecal microbial transplantation is a milestone in microbiome medicine, and its commercialization potential is closely related to the depth of intestinal flora research and the maturity of the regulatory framework.
This report aims to provide a comprehensive presentation of the global market for Fecal Transplant Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fecal Transplant Treatment.
The Fecal Transplant Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fecal Transplant Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fecal Transplant Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Enterome
Ferring Pharmaceuticals
Finch Therapeutics Group
MaaT Pharma
Seres Therapeutics
OpenBiome
Qualigen Therapeutics
Vedanta Biosciences
Segment by Type
Transcolonoscopic Transplantation
Nasoenteric Tube Perfusion
Oral Capsule
Segment by Application
Clostridium Difficile Infection (CDI)
Inflammatory Bowel Disease (IBD)
Irritable Bowel Syndrome (IBS)
Metabolic Syndrome
Neurological Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fecal Transplant Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fecal Transplant Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Transcolonoscopic Transplantation
1.2.3 Nasoenteric Tube Perfusion
1.2.4 Oral Capsule
1.3 Market by Application
1.3.1 Global Fecal Transplant Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clostridium Difficile Infection (CDI)
1.3.3 Inflammatory Bowel Disease (IBD)
1.3.4 Irritable Bowel Syndrome (IBS)
1.3.5 Metabolic Syndrome
1.3.6 Neurological Diseases
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fecal Transplant Treatment Market Perspective (2020-2031)
2.2 Global Fecal Transplant Treatment Growth Trends by Region
2.2.1 Global Fecal Transplant Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Fecal Transplant Treatment Historic Market Size by Region (2020-2025)
2.2.3 Fecal Transplant Treatment Forecasted Market Size by Region (2026-2031)
2.3 Fecal Transplant Treatment Market Dynamics
2.3.1 Fecal Transplant Treatment Industry Trends
2.3.2 Fecal Transplant Treatment Market Drivers
2.3.3 Fecal Transplant Treatment Market Challenges
2.3.4 Fecal Transplant Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fecal Transplant Treatment Players by Revenue
3.1.1 Global Top Fecal Transplant Treatment Players by Revenue (2020-2025)
3.1.2 Global Fecal Transplant Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Top Fecal Transplant Treatment Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Fecal Transplant Treatment Revenue
3.4 Global Fecal Transplant Treatment Market Concentration Ratio
3.4.1 Global Fecal Transplant Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fecal Transplant Treatment Revenue in 2024
3.5 Global Key Players of Fecal Transplant Treatment Head office and Area Served
3.6 Global Key Players of Fecal Transplant Treatment, Product and Application
3.7 Global Key Players of Fecal Transplant Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Fecal Transplant Treatment Breakdown Data by Type
4.1 Global Fecal Transplant Treatment Historic Market Size by Type (2020-2025)
4.2 Global Fecal Transplant Treatment Forecasted Market Size by Type (2026-2031)
5 Fecal Transplant Treatment Breakdown Data by Application
5.1 Global Fecal Transplant Treatment Historic Market Size by Application (2020-2025)
5.2 Global Fecal Transplant Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Fecal Transplant Treatment Market Size (2020-2031)
6.2 North America Fecal Transplant Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Fecal Transplant Treatment Market Size by Country (2020-2025)
6.4 North America Fecal Transplant Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fecal Transplant Treatment Market Size (2020-2031)
7.2 Europe Fecal Transplant Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Fecal Transplant Treatment Market Size by Country (2020-2025)
7.4 Europe Fecal Transplant Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fecal Transplant Treatment Market Size (2020-2031)
8.2 Asia-Pacific Fecal Transplant Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Fecal Transplant Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Fecal Transplant Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fecal Transplant Treatment Market Size (2020-2031)
9.2 Latin America Fecal Transplant Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Fecal Transplant Treatment Market Size by Country (2020-2025)
9.4 Latin America Fecal Transplant Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fecal Transplant Treatment Market Size (2020-2031)
10.2 Middle East & Africa Fecal Transplant Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Fecal Transplant Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Fecal Transplant Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Enterome
11.1.1 Enterome Company Details
11.1.2 Enterome Business Overview
11.1.3 Enterome Fecal Transplant Treatment Introduction
11.1.4 Enterome Revenue in Fecal Transplant Treatment Business (2020-2025)
11.1.5 Enterome Recent Development
11.2 Ferring Pharmaceuticals
11.2.1 Ferring Pharmaceuticals Company Details
11.2.2 Ferring Pharmaceuticals Business Overview
11.2.3 Ferring Pharmaceuticals Fecal Transplant Treatment Introduction
11.2.4 Ferring Pharmaceuticals Revenue in Fecal Transplant Treatment Business (2020-2025)
11.2.5 Ferring Pharmaceuticals Recent Development
11.3 Finch Therapeutics Group
11.3.1 Finch Therapeutics Group Company Details
11.3.2 Finch Therapeutics Group Business Overview
11.3.3 Finch Therapeutics Group Fecal Transplant Treatment Introduction
11.3.4 Finch Therapeutics Group Revenue in Fecal Transplant Treatment Business (2020-2025)
11.3.5 Finch Therapeutics Group Recent Development
11.4 MaaT Pharma
11.4.1 MaaT Pharma Company Details
11.4.2 MaaT Pharma Business Overview
11.4.3 MaaT Pharma Fecal Transplant Treatment Introduction
11.4.4 MaaT Pharma Revenue in Fecal Transplant Treatment Business (2020-2025)
11.4.5 MaaT Pharma Recent Development
11.5 Seres Therapeutics
11.5.1 Seres Therapeutics Company Details
11.5.2 Seres Therapeutics Business Overview
11.5.3 Seres Therapeutics Fecal Transplant Treatment Introduction
11.5.4 Seres Therapeutics Revenue in Fecal Transplant Treatment Business (2020-2025)
11.5.5 Seres Therapeutics Recent Development
11.6 OpenBiome
11.6.1 OpenBiome Company Details
11.6.2 OpenBiome Business Overview
11.6.3 OpenBiome Fecal Transplant Treatment Introduction
11.6.4 OpenBiome Revenue in Fecal Transplant Treatment Business (2020-2025)
11.6.5 OpenBiome Recent Development
11.7 Qualigen Therapeutics
11.7.1 Qualigen Therapeutics Company Details
11.7.2 Qualigen Therapeutics Business Overview
11.7.3 Qualigen Therapeutics Fecal Transplant Treatment Introduction
11.7.4 Qualigen Therapeutics Revenue in Fecal Transplant Treatment Business (2020-2025)
11.7.5 Qualigen Therapeutics Recent Development
11.8 Vedanta Biosciences
11.8.1 Vedanta Biosciences Company Details
11.8.2 Vedanta Biosciences Business Overview
11.8.3 Vedanta Biosciences Fecal Transplant Treatment Introduction
11.8.4 Vedanta Biosciences Revenue in Fecal Transplant Treatment Business (2020-2025)
11.8.5 Vedanta Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Fecal Transplant Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Transcolonoscopic Transplantation
Table 3. Key Players of Nasoenteric Tube Perfusion
Table 4. Key Players of Oral Capsule
Table 5. Global Fecal Transplant Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Fecal Transplant Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Fecal Transplant Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Fecal Transplant Treatment Market Share by Region (2020-2025)
Table 9. Global Fecal Transplant Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Fecal Transplant Treatment Market Share by Region (2026-2031)
Table 11. Fecal Transplant Treatment Market Trends
Table 12. Fecal Transplant Treatment Market Drivers
Table 13. Fecal Transplant Treatment Market Challenges
Table 14. Fecal Transplant Treatment Market Restraints
Table 15. Global Fecal Transplant Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Fecal Transplant Treatment Market Share by Players (2020-2025)
Table 17. Global Top Fecal Transplant Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fecal Transplant Treatment as of 2024)
Table 18. Ranking of Global Top Fecal Transplant Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Fecal Transplant Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Fecal Transplant Treatment, Headquarters and Area Served
Table 21. Global Key Players of Fecal Transplant Treatment, Product and Application
Table 22. Global Key Players of Fecal Transplant Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Fecal Transplant Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Fecal Transplant Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Fecal Transplant Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Fecal Transplant Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Fecal Transplant Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Fecal Transplant Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Fecal Transplant Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Fecal Transplant Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Fecal Transplant Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Fecal Transplant Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Fecal Transplant Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Fecal Transplant Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Fecal Transplant Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Fecal Transplant Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Fecal Transplant Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Fecal Transplant Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Fecal Transplant Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Fecal Transplant Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Fecal Transplant Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Fecal Transplant Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Fecal Transplant Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Fecal Transplant Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Fecal Transplant Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Enterome Company Details
Table 48. Enterome Business Overview
Table 49. Enterome Fecal Transplant Treatment Product
Table 50. Enterome Revenue in Fecal Transplant Treatment Business (2020-2025) & (US$ Million)
Table 51. Enterome Recent Development
Table 52. Ferring Pharmaceuticals Company Details
Table 53. Ferring Pharmaceuticals Business Overview
Table 54. Ferring Pharmaceuticals Fecal Transplant Treatment Product
Table 55. Ferring Pharmaceuticals Revenue in Fecal Transplant Treatment Business (2020-2025) & (US$ Million)
Table 56. Ferring Pharmaceuticals Recent Development
Table 57. Finch Therapeutics Group Company Details
Table 58. Finch Therapeutics Group Business Overview
Table 59. Finch Therapeutics Group Fecal Transplant Treatment Product
Table 60. Finch Therapeutics Group Revenue in Fecal Transplant Treatment Business (2020-2025) & (US$ Million)
Table 61. Finch Therapeutics Group Recent Development
Table 62. MaaT Pharma Company Details
Table 63. MaaT Pharma Business Overview
Table 64. MaaT Pharma Fecal Transplant Treatment Product
Table 65. MaaT Pharma Revenue in Fecal Transplant Treatment Business (2020-2025) & (US$ Million)
Table 66. MaaT Pharma Recent Development
Table 67. Seres Therapeutics Company Details
Table 68. Seres Therapeutics Business Overview
Table 69. Seres Therapeutics Fecal Transplant Treatment Product
Table 70. Seres Therapeutics Revenue in Fecal Transplant Treatment Business (2020-2025) & (US$ Million)
Table 71. Seres Therapeutics Recent Development
Table 72. OpenBiome Company Details
Table 73. OpenBiome Business Overview
Table 74. OpenBiome Fecal Transplant Treatment Product
Table 75. OpenBiome Revenue in Fecal Transplant Treatment Business (2020-2025) & (US$ Million)
Table 76. OpenBiome Recent Development
Table 77. Qualigen Therapeutics Company Details
Table 78. Qualigen Therapeutics Business Overview
Table 79. Qualigen Therapeutics Fecal Transplant Treatment Product
Table 80. Qualigen Therapeutics Revenue in Fecal Transplant Treatment Business (2020-2025) & (US$ Million)
Table 81. Qualigen Therapeutics Recent Development
Table 82. Vedanta Biosciences Company Details
Table 83. Vedanta Biosciences Business Overview
Table 84. Vedanta Biosciences Fecal Transplant Treatment Product
Table 85. Vedanta Biosciences Revenue in Fecal Transplant Treatment Business (2020-2025) & (US$ Million)
Table 86. Vedanta Biosciences Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report


List of Figures
Figure 1. Fecal Transplant Treatment Picture
Figure 2. Global Fecal Transplant Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Fecal Transplant Treatment Market Share by Type: 2024 VS 2031
Figure 4. Transcolonoscopic Transplantation Features
Figure 5. Nasoenteric Tube Perfusion Features
Figure 6. Oral Capsule Features
Figure 7. Global Fecal Transplant Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Fecal Transplant Treatment Market Share by Application: 2024 VS 2031
Figure 9. Clostridium Difficile Infection (CDI) Case Studies
Figure 10. Inflammatory Bowel Disease (IBD) Case Studies
Figure 11. Irritable Bowel Syndrome (IBS) Case Studies
Figure 12. Metabolic Syndrome Case Studies
Figure 13. Neurological Diseases Case Studies
Figure 14. Others Case Studies
Figure 15. Fecal Transplant Treatment Report Years Considered
Figure 16. Global Fecal Transplant Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Fecal Transplant Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Fecal Transplant Treatment Market Share by Region: 2024 VS 2031
Figure 19. Global Fecal Transplant Treatment Market Share by Players in 2024
Figure 20. Global Fecal Transplant Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Fecal Transplant Treatment Revenue in 2024
Figure 22. North America Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Fecal Transplant Treatment Market Share by Country (2020-2031)
Figure 24. United States Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Fecal Transplant Treatment Market Share by Country (2020-2031)
Figure 28. Germany Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Fecal Transplant Treatment Market Share by Region (2020-2031)
Figure 36. China Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Fecal Transplant Treatment Market Share by Country (2020-2031)
Figure 44. Mexico Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Fecal Transplant Treatment Market Share by Country (2020-2031)
Figure 48. Turkey Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Fecal Transplant Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Enterome Revenue Growth Rate in Fecal Transplant Treatment Business (2020-2025)
Figure 52. Ferring Pharmaceuticals Revenue Growth Rate in Fecal Transplant Treatment Business (2020-2025)
Figure 53. Finch Therapeutics Group Revenue Growth Rate in Fecal Transplant Treatment Business (2020-2025)
Figure 54. MaaT Pharma Revenue Growth Rate in Fecal Transplant Treatment Business (2020-2025)
Figure 55. Seres Therapeutics Revenue Growth Rate in Fecal Transplant Treatment Business (2020-2025)
Figure 56. OpenBiome Revenue Growth Rate in Fecal Transplant Treatment Business (2020-2025)
Figure 57. Qualigen Therapeutics Revenue Growth Rate in Fecal Transplant Treatment Business (2020-2025)
Figure 58. Vedanta Biosciences Revenue Growth Rate in Fecal Transplant Treatment Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies